All terms in GO

Label Id Description
NMDA selective glutamate receptor complex GO_0017146 [An assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex. NMDA receptors are composed of assemblies of NR1 subunits (Figure 3) and NR2 subunits, which can be one of four separate gene products (NR2A-D). Expression of both subunits are required to form functional channels. The glutamate binding domain is formed at the junction of NR1 and NR2 subunits. NMDA receptors are permeable to calcium ions as well as being permeable to other ions. Thus NMDA receptor activation leads to a calcium influx into the post-synaptic cells, a signal thought to be crucial for the induction of NMDA-receptor dependent LTP and LTD.]
ionotropic glutamate receptor complex GO_0008328 [A multimeric assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand-gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex.]
GO_0017144 GO_0017144
obsolete toxin susceptibility/resistance GO_0017142 [OBSOLETE. (Was not defined before being made obsolete).]
obsolete antibiotic susceptibility/resistance GO_0017141 [OBSOLETE. (Was not defined before being made obsolete).]
GO_0017140 GO_0017140
tRNA dihydrouridine synthase activity GO_0017150 [Catalysis of the reaction: a 5,6-dihydrouridine in tRNA + NAD(P)+ = a uridine in tRNA + H+ + NAD(P)H.]
RNA dihydrouridine synthase activity GO_0106413 [Catalysis of the reaction: RNA-uracil + NAD(P)+ = RNA-dihydrouridine + NAD(P)H + H+.]
NHE3/E3KARP/ACTN4 complex GO_0032766 [A heterotrimeric protein complex formed by the association of NHE3, E3KARP and alpha-actinin upon an increase in calcium ion concentration; found in clusters localized on plasma membrane and in intracellular compartments.]
positive regulation of mast cell cytokine production GO_0032765 [Any process that activates or increases the frequency, rate, or extent of mast cell cytokine production.]
copper-dependent protein binding GO_0032767 [Binding to a protein or protein complex, in the presence of copper.]
lead ion binding GO_0032791 [Binding to lead (Pb) ions.]
ribosome disassembly GO_0032790 [The disaggregation of a ribosome into its constituent components; includes the dissociation of ribosomal subunits.]
positive regulation of CREB transcription factor activity GO_0032793 [Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.]
neutrophil activation GO_0042119 [The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.]
negative regulation of CREB transcription factor activity GO_0032792 [Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor CREB.]
negative regulation of DNA-binding transcription factor activity GO_0043433 [Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.]
endothelial cell activation GO_0042118 [The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.]
heterotrimeric G-protein binding GO_0032795 [Binding to a heterotrimeric G-protein.]
monocyte activation GO_0042117 [The change in morphology and behavior of a monocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.]